share_log

Litchfield Hills Initiates Coverage On Mateon Therapeutics with Buy Rating, Announces Price Target of $3

Litchfield Hills Initiates Coverage On Mateon Therapeutics with Buy Rating, Announces Price Target of $3

Litchfield Hills以買入評級啟動對Mateon治療公司的覆蓋,宣佈目標價為3美元
Benzinga Real-time News ·  2020/12/07 07:25

Litchfield Hills initiates coverage on Mateon Therapeutics (OTC:MATN) with a Buy rating and announces Price Target of $3.

Litchfield Hills啟動對Mateon Treeutics(OTC:材料),買入評級,並宣佈目標價為3美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論